Page 37 - Colitis Foundation News Today

SAN DIEGO, Sept. 07, 2022 -- Biora Therapeutics, Inc. , the biotech company that is reimagining therapeutics, announced today the appointment of Dr. Bruce Sands as board chair of its Clinical... | September 7, 2022

A growing number of physicians are adapting ecologic approaches to boost the gut microbiomes of vulnerable communities in an effort to prevent common diseases, like IBD, before they occur.

Annual list recognizes innovators and leaders in life-sciences who positively impact the industry at largeCAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that Jonathan Ng, MBBS, the company’s founder and CEO, has been named to th...

The Country Friends Art of Fashion show returns The Country Friends Art of Fashion, the nonprofit’s tribute to fall and philanthropy, takes to the runway at The Inn at Rancho Santa Fe on Sept. 15.

Crohn’s disease is a chronic inflammatory bowel disease that involves inflammation in all or part of the digestive tract

Microvillus Inclusion Disease (MVID), a CDD, Is a Life-Threatening and Rare Autosomal Recessive Disease That Affects Newborns and Children and Leads to Significant Morbidity and Mortality From Severe Secretory

Jaguar Health Provides Company Updates and Reports 2022 Second Quarter Financials - read this article along with other careers information, tips and advice on BioSpace

A group of Houston leading ladies recently received a surprise honor for their tireless work in the community.  The Crohn’s & Colitis Foun

EngageSmart, Inc. (NYSE:NYSE:ESMT) Q2 2022 Earnings Conference Call August 4, 2022 08:30 a.m.

ESMT earnings call for the period ending June 30, 2022.